014sek
13,8 %
Date:2024-04-26Time:09:42:00Latest report:Q4-2023List:NGMTicker:PRLD
Market Cap:70 msekEnterprise Value:57 msekNet Sales:- msekEarnings:-27,8 msekEmployees:0ISIN:SE0003618230

Ratios

10-year key figure history for Prolight Diagnostics turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Prolight Diagnostics with index and moving average MA50 and MA200.

Stockprice:0,14
MA50:0,17
MA200:0,51
Price/MA200:-72,2 %
RSI (14):41,2
Price/MA50:-19,1 %

Description

Prolight Diagnostics AB is developing with technology partners near-patient test system based on the patented technology, for use in so-called Point of Care Testing (POCT). The company uses technology such as Mico ELISA and Flex membrane and PLD Micro Flex.

Biotechnology